---
title: "postmonarch"
date: "2024-07-21"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[Abemaciclb]]

# postmonarch

![h:450px](https://i.imgur.com/niFZbDd.png)

- switching CDKi at PD improve survival

### References

> [postMONARCH: A phase 3 study of abemaciclib plus fulvestrant versus placebo plus fulvestrant in patients with HR+, HER2-, metastatic breast cancer following progression on a CDK4 & 6 inhibitor and endocrine therapy. | Journal of Clinical Oncology](https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.TPS1117)
